Work

Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)

Year: 2008

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdn154

Authors: E. Mrozek, J. Kolesar, D. Young, J. Allen, M. Villalona-Calero, C.L. Shapiro

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Peking University Cancer Hospital, University of Wisconsin–Madison, The Ohio State University

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Comprehensive Cancer Network

OpenAlex ID: W2098024069

FWCI: 0.683

Cites: 39

Cited by: 19

Related to: 10